OSUR Key Statistics, Chart & Performance
The current stock price of OSUR is 2.38 USD. In the past month the price decreased by -11.85%. In the past year, price decreased by -37.37%.
OSUR Latest News, Press Relases and Analysis
OSUR Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| COO | COOPER COS INC/THE | 19.39 | 15.49B | ||
| SOLV | SOLVENTUM CORP | 14.35 | 14.79B | ||
| ALGN | ALIGN TECHNOLOGY INC | 15.22 | 10.56B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 23.28 | 5.13B | ||
| LNTH | LANTHEUS HOLDINGS INC | 9.88 | 3.90B | ||
| HAE | HAEMONETICS CORP/MASS | 16.95 | 3.81B | ||
| ICUI | ICU MEDICAL INC | 18.65 | 3.66B | ||
| XRAY | DENTSPLY SIRONA INC | 7.18 | 2.26B | ||
| UFPT | UFP TECHNOLOGIES INC | 26.27 | 1.75B | ||
| NEOG | NEOGEN CORP | 19.93 | 1.30B | ||
| STAA | STAAR SURGICAL CO | N/A | 1.32B | ||
| EMBC | EMBECTA CORP | 4.29 | 746.04M |
Related stock screener links
About OSUR
Company Profile
OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic tests and molecular collection devices designed to detect or diagnose critical medical conditions. The company is headquartered in Bethlehem, Pennsylvania and currently employs 501 full-time employees. The firm's product portfolio is divided into diagnostics products and sample management solutions. Its business consists of the development, manufacture, marketing and sale of diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types. Its diagnostic products include tests for diseases including COVID-19, HIV, Hepatitis C and Syphilis that are performed on a rapid basis at the point of care. Its business also includes sample management solutions and services that are used by clinical laboratories, direct-to-consumer laboratories, researchers, pharmaceutical companies, and animal health service and product providers.
Company Info
ORASURE TECHNOLOGIES INC
220 E First St
Bethlehem PENNSYLVANIA 18015 US
CEO: Stephen S. Tang
Employees: 501
Phone: 15036416115
ORASURE TECHNOLOGIES INC / OSUR FAQ
What does ORASURE TECHNOLOGIES INC do?
OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic tests and molecular collection devices designed to detect or diagnose critical medical conditions. The company is headquartered in Bethlehem, Pennsylvania and currently employs 501 full-time employees. The firm's product portfolio is divided into diagnostics products and sample management solutions. Its business consists of the development, manufacture, marketing and sale of diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types. Its diagnostic products include tests for diseases including COVID-19, HIV, Hepatitis C and Syphilis that are performed on a rapid basis at the point of care. Its business also includes sample management solutions and services that are used by clinical laboratories, direct-to-consumer laboratories, researchers, pharmaceutical companies, and animal health service and product providers.
Can you provide the latest stock price for ORASURE TECHNOLOGIES INC?
The current stock price of OSUR is 2.38 USD.
What is the dividend status of ORASURE TECHNOLOGIES INC?
OSUR does not pay a dividend.
What is the ChartMill technical and fundamental rating of OSUR stock?
OSUR has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Can you provide the upcoming earnings date for ORASURE TECHNOLOGIES INC?
ORASURE TECHNOLOGIES INC (OSUR) will report earnings on 2026-02-23, after the market close.
Who owns ORASURE TECHNOLOGIES INC?
You can find the ownership structure of ORASURE TECHNOLOGIES INC (OSUR) on the Ownership tab.
What is the outstanding short interest for ORASURE TECHNOLOGIES INC?
The outstanding short interest for ORASURE TECHNOLOGIES INC (OSUR) is 5.47% of its float.
OSUR Technical Analysis
OSUR Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to OSUR. OSUR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
OSUR Financial Highlights
Over the last trailing twelve months OSUR reported a non-GAAP Earnings per Share(EPS) of -0.8. The EPS decreased by -633.33% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -14.24% | ||
| ROE | -16.64% | ||
| Debt/Equity | 0 |
OSUR Forecast & Estimates
8 analysts have analysed OSUR and the average price target is 4.59 USD. This implies a price increase of 92.86% is expected in the next year compared to the current price of 2.38.
For the next year, analysts expect an EPS growth of -241.31% and a revenue growth -34.82% for OSUR